EcoGraf posts strongest gains in over four years following the grant of a Special Mining Licence at the Epanko graphite ...

High-grade veins have been hit at Copalquin, where MTH (ASX:MTH) aims to grow the footprint and knowledge of a NW trending ...

Aussie companies delivered a mixed bag of results, with experts impressed by A2 Milk Company but not so much by Bendigo and ...

Recharge Metals (ASX:REC) has begun an IP survey on its hunt for porphyry copper at its Brandy Hill South project in the WA ...

ASX fell after Trump’s tariffs spooked the market, with Canada and China firing back while Suncorp, Insignia and HCW got ...

ASX explorers are intensifying exploration efforts at silver, gold and lithium projects in Nevada as the US looks to boost ...

Australia’s S&P/ASX 200 fell 4% in February as global geopolitical and economic uncertainties rattled markets.

Rusty Delroy returns for Counter Cycle and this time he tells us why he sees big opportunities in the sold off platinum group ...

ASX dives after Trump’s tariff news, with Aussie miners and tech stocks copping it, while Suncorp drops further ...

February was a wild ride with Trump’s tariffs sending markets into chaos and ASX tech taking a serious dive, led by ...

Mithril shares gained strongly on gold and silver hits, with yet more drilling to come at its Copalquin project in Mexico.

Multiple system atrophy (MSA) is not exactly a household word – a situation that Alterity Therapeutics is seeking to change.